Cuspidi Cesare, Michev Iassen, Meani Stefano, Valerio Cristiana, Bertazzoli Giovanni, Magrini Fabio, Zanchetti Alberto
Clinica Medica Generale e Terapia Medica, Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Ospedale Maggiore Policlinico IRCCS, Milan, Italy.
Cardiovasc Ultrasound. 2003 Feb 14;1:1. doi: 10.1186/1476-7120-1-1.
Non-dipping pattern in hypertensive patients has been shown to be associated with an excess of target organ damage and with an adverse outcome. The aim of our study was to assess whether a reduced nocturnal fall in blood pressure (BP), established on the basis of a single 24-h BP monitoring, in treated essential hypertensives is related to more prominent cardiac alterations.
We enrolled 229 treated hypertensive patients attending the out-patient clinic of our hypertension centre; each patient was subjected to the following procedures : 1) clinic BP measurement; 2) blood and urine sampling for routine blood chemistry and urine examination; 3) standard 12-lead electrocardiogram; 4) echocardiography; 5) ambulatory BP monitoring (ABPM). For the purpose of this study ABPM was carried-out in three subgroups with different clinic BP profile: 1) patients with satisfactory BP control (BP < 140/90 mmHg; group I, n = 58); 2) patients with uncontrolled clinic BP (clinic BP values > or = 140 and/or 90 mmHg) but lower self-measured BP (< 20 mmHg for systolic BP and/or 10 mmHg for diastolic BP; group II, n = 72); 3) patients with refractory hypertension, selected according to WHO/ISH guidelines definition (group III, n = 99). Left ventricular hypertrophy (LVH) was defined by two gender-specific criteria (LV mass index > or = 125/m2 in men and 110 g/m2 in women, > or = 51/gm2.7 in men and 47/g/m2.7 in women).
Of the 229 study participants 119 (51.9%) showed a fall in SBP/DBP < 10% during the night (non-dippers). The prevalence of non-dippers was significantly lower in group I (44.8%) and II (41.6%) than in group III (63.9%, p < 0.01 III vs II and I). The prevalence of LVH varied from 10.3 to 24.1% in group I, 31.9 to 43.1% in group II and from 60.6 to 67.7% in group III (p < 0.01, III vs II and I). No differences in cardiac structure, analysed as continuous variable as well as prevalence of LVH, were found in relationship to dipping or non-dipping status in the three groups.
In treated essential hypertensives with or without BP control the extent of nocturnal BP decrease is not associated with an increase in LV mass or LVH prevalence; therefore, the non-dipping profile, diagnosed on the basis of a single ABPM, does not identify hypertensive patients with greater cardiac damage.
高血压患者的血压非勺型模式已被证明与靶器官损害过多及不良预后相关。我们研究的目的是评估在接受治疗的原发性高血压患者中,基于单次24小时血压监测确定的夜间血压下降幅度减小是否与更显著的心脏改变有关。
我们纳入了229名在我们高血压中心门诊就诊的接受治疗的高血压患者;每位患者接受了以下检查:1)诊室血压测量;2)采集血液和尿液样本进行常规血液生化和尿液检查;3)标准12导联心电图;4)超声心动图;5)动态血压监测(ABPM)。为了本研究的目的,ABPM在三个具有不同诊室血压特征的亚组中进行:1)血压控制良好的患者(血压<140/90 mmHg;第一组,n = 58);2)诊室血压未得到控制的患者(诊室血压值≥140和/或90 mmHg)但自测血压较低(收缩压<20 mmHg和/或舒张压<10 mmHg;第二组,n = 72);3)根据世界卫生组织/国际高血压学会指南定义选择的顽固性高血压患者(第三组,n = 99)。左心室肥厚(LVH)由两个性别特异性标准定义(男性LV质量指数≥125 g/m²,女性≥110 g/m²,男性≥51 g/m².⁷,女性≥47 g/m².⁷)。
在229名研究参与者中,119名(51.9%)夜间收缩压/舒张压下降幅度<10%(非勺型者)。非勺型者的患病率在第一组(44.8%)和第二组(41.6%)中显著低于第三组(63.9%,第三组与第二组和第一组相比,p<0.01)。左心室肥厚的患病率在第一组为10.3%至24.1%,在第二组为31.9%至43.1%,在第三组为60.6%至67.7%(第三组与第二组和第一组相比,p<0.01)。在三组中,无论作为连续变量分析的心脏结构还是左心室肥厚的患病率,在勺型或非勺型状态方面均未发现差异。
在接受治疗的原发性高血压患者中,无论血压是否得到控制,夜间血压下降的程度与左心室质量增加或左心室肥厚患病率的增加均无关;因此,基于单次ABPM诊断的非勺型模式并不能识别出心脏损害更大的高血压患者。